Evidence map›Paper›PMID 39189453›Full record

ArticleNucleic acids research2024

Mechanism of structure-specific DNA binding by the FANCM branchpoint translocase.

Lara Abbouche, Vincent J Murphy, Jixuan Gao, Sylvie van Twest, Alexander P Sobinoff, Karen M Auweiler, Hilda A Pickett, Rohan Bythell-Douglas, Andrew J Deans

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Ubiquitin and SUMO pathways in DNA replication and replication-coupled repair.Critical reviews in biochemistry and molecular biology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lara AbboucheGenome Stability Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC, Australia.
Vincent J MurphyGenome Stability Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC, Australia.
Jixuan GaoChildren's Medical Research Institute, Westmead, NSW, Australia.
Sylvie van TwestGenome Stability Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC, Australia.
Alexander P SobinoffChildren's Medical Research Institute, Westmead, NSW, Australia.
Karen M AuweilerGenome Stability Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC, Australia.
Hilda A PickettChildren's Medical Research Institute, Westmead, NSW, Australia.ORCID 0000-0002-9840-4841
Rohan Bythell-DouglasGenome Stability Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC, Australia.
Andrew J DeansGenome Stability Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC, Australia.ORCID 0000-0002-5271-4422

Funding

Medical research future fund (Australia) MRFF2007488National Breast Cancer Foundation IIRS-19-017National Health and Medical Research Council GNT1181110
6 · The paper itself

Abstract

FANCM is a DNA repair protein that recognizes stalled replication forks, and recruits downstream repair factors. FANCM activity is also essential for the survival of cancer cells that utilize the Alternative Lengthening of Telomeres (ALT) mechanism. FANCM efficiently recognizes stalled replication forks in the genome or at telomeres through its strong affinity for branched DNA structures. In this study, we demonstrate that the N-terminal translocase domain drives this specific branched DNA recognition. The Hel2i subdomain within the translocase is crucial for effective substrate engagement and couples DNA binding to catalytic ATP-dependent branch migration. Removal of Hel2i or mutation of key DNA-binding residues within this domain diminished FANCM's affinity for junction DNA and abolished branch migration activity. Importantly, these mutant FANCM variants failed to rescue the cell cycle arrest, telomere-associated replication stress, or lethality of ALT-positive cancer cells depleted of endogenous FANCM. Our results reveal the Hel2i domain is key for FANCM to properly engage DNA substrates, and therefore plays an essential role in its tumour-suppressive functions by restraining the hyperactivation of the ALT pathway.

Indexed as

DNADNA HelicasesDNA ReplicationHumansMutationProtein BindingProtein DomainsTelomereTelomere HomeostasisDNADNA HelicasesFANCM protein, human

Identifiers

PMID39189453
PMCPMC11472164

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.